Biosenta Inc.
ZRO
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.00% | 200.00% | -48,800.00% | 146,200.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00% | 200.00% | -48,800.00% | 146,200.00% | 0.00% |
| Cost of Revenue | 0.00% | 0.00% | 0.00% | -96.15% | 0.00% |
| Gross Profit | 0.00% | 100.00% | -146,300.00% | 5,952.00% | -- |
| SG&A Expenses | 83.56% | -1.93% | -23.53% | -24.59% | -49.26% |
| Depreciation & Amortization | -66.67% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.17% | 0.22% | -29.82% | -23.46% | -45.16% |
| Operating Income | -71.27% | -0.05% | -19.00% | 63.33% | 45.22% |
| Income Before Tax | -29.00% | -21.20% | 86.56% | -8.67% | -47.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.00% | -21.20% | 86.56% | -8.67% | -47.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.00% | -21.20% | 86.56% | -8.67% | -47.47% |
| EBIT | -71.27% | -0.05% | -19.00% | 63.33% | 45.22% |
| EBITDA | -71.53% | -- | -- | -- | -- |
| EPS Basic | -7.46% | 1.53% | 85.09% | 13.13% | -24.07% |
| Normalized Basic EPS | -7.14% | 1.22% | -77.59% | 13.00% | -23.53% |
| EPS Diluted | -7.46% | 1.53% | 85.09% | 13.13% | -24.07% |
| Normalized Diluted EPS | -7.14% | 1.22% | -77.59% | 13.00% | -23.53% |
| Average Basic Shares Outstanding | 19.89% | 22.65% | -9.94% | 24.82% | 19.44% |
| Average Diluted Shares Outstanding | 19.89% | 22.65% | -9.94% | 24.82% | 19.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |